世界の腸内細菌科感染症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Enterobacteriaceae Infection Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4190 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、腸内細菌科感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベータラクタム薬剤、カルバペネム薬剤、フルオロキノロン薬剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腸内細菌科感染症治療薬の市場動向 ・企業の競争状況、市場シェア ・腸内細菌科感染症治療薬の種類別市場規模と予測2016-2027（ベータラクタム薬剤、カルバペネム薬剤、フルオロキノロン薬剤、その他） ・腸内細菌科感染症治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・腸内細菌科感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・腸内細菌科感染症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腸内細菌科感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腸内細菌科感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・腸内細菌科感染症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genentech、Nanotherapeutics、Novartis、Pfizer、Nymox Pharmaceutical、Sequoia Sciences、Phico Therapeutics、Cantab Biopharmaceuticals） ・結論

Enterobacteriaceae infections are caused by Enterobacter species, pathogens responsible for causing severe infections including bacteremia, urinary tract infections, lower respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections.

Market Analysis and Insights: Global Enterobacteriaceae Infection Drug Market
The global Enterobacteriaceae Infection Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Enterobacteriaceae Infection Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Enterobacteriaceae Infection Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Enterobacteriaceae Infection Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Enterobacteriaceae Infection Drug market.

Global Enterobacteriaceae Infection Drug Scope and Market Size
Enterobacteriaceae Infection Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enterobacteriaceae Infection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Beta-lactams Drugs
Carbapenems Drugs
Fluoroquinolones Drugs
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genentech
Nanotherapeutics
Novartis
Pfizer
Nymox Pharmaceutical
Sequoia Sciences
Phico Therapeutics
Cantab Biopharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Beta-lactams Drugs
1.2.3 Carbapenems Drugs
1.2.4 Fluoroquinolones Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Enterobacteriaceae Infection Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Enterobacteriaceae Infection Drug Market Perspective (2016-2027)
2.2 Enterobacteriaceae Infection Drug Growth Trends by Regions
2.2.1 Enterobacteriaceae Infection Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Enterobacteriaceae Infection Drug Historic Market Share by Regions (2016-2021)
2.2.3 Enterobacteriaceae Infection Drug Forecasted Market Size by Regions (2022-2027)
2.3 Enterobacteriaceae Infection Drug Industry Dynamic
2.3.1 Enterobacteriaceae Infection Drug Market Trends
2.3.2 Enterobacteriaceae Infection Drug Market Drivers
2.3.3 Enterobacteriaceae Infection Drug Market Challenges
2.3.4 Enterobacteriaceae Infection Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue
3.1.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue (2016-2021)
3.1.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Players (2016-2021)
3.2 Global Enterobacteriaceae Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Enterobacteriaceae Infection Drug Revenue
3.4 Global Enterobacteriaceae Infection Drug Market Concentration Ratio
3.4.1 Global Enterobacteriaceae Infection Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enterobacteriaceae Infection Drug Revenue in 2020
3.5 Enterobacteriaceae Infection Drug Key Players Head office and Area Served
3.6 Key Players Enterobacteriaceae Infection Drug Product Solution and Service
3.7 Date of Enter into Enterobacteriaceae Infection Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Enterobacteriaceae Infection Drug Breakdown Data by Type
4.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Type (2016-2021)
4.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2022-2027)

5 Enterobacteriaceae Infection Drug Breakdown Data by Application
5.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Application (2016-2021)
5.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Enterobacteriaceae Infection Drug Market Size (2016-2027)
6.2 North America Enterobacteriaceae Infection Drug Market Size by Type
6.2.1 North America Enterobacteriaceae Infection Drug Market Size by Type (2016-2021)
6.2.2 North America Enterobacteriaceae Infection Drug Market Size by Type (2022-2027)
6.2.3 North America Enterobacteriaceae Infection Drug Market Size by Type (2016-2027)
6.3 North America Enterobacteriaceae Infection Drug Market Size by Application
6.3.1 North America Enterobacteriaceae Infection Drug Market Size by Application (2016-2021)
6.3.2 North America Enterobacteriaceae Infection Drug Market Size by Application (2022-2027)
6.3.3 North America Enterobacteriaceae Infection Drug Market Size by Application (2016-2027)
6.4 North America Enterobacteriaceae Infection Drug Market Size by Country
6.4.1 North America Enterobacteriaceae Infection Drug Market Size by Country (2016-2021)
6.4.2 North America Enterobacteriaceae Infection Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Enterobacteriaceae Infection Drug Market Size (2016-2027)
7.2 Europe Enterobacteriaceae Infection Drug Market Size by Type
7.2.1 Europe Enterobacteriaceae Infection Drug Market Size by Type (2016-2021)
7.2.2 Europe Enterobacteriaceae Infection Drug Market Size by Type (2022-2027)
7.2.3 Europe Enterobacteriaceae Infection Drug Market Size by Type (2016-2027)
7.3 Europe Enterobacteriaceae Infection Drug Market Size by Application
7.3.1 Europe Enterobacteriaceae Infection Drug Market Size by Application (2016-2021)
7.3.2 Europe Enterobacteriaceae Infection Drug Market Size by Application (2022-2027)
7.3.3 Europe Enterobacteriaceae Infection Drug Market Size by Application (2016-2027)
7.4 Europe Enterobacteriaceae Infection Drug Market Size by Country
7.4.1 Europe Enterobacteriaceae Infection Drug Market Size by Country (2016-2021)
7.4.2 Europe Enterobacteriaceae Infection Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size (2016-2027)
8.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type
8.2.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application
8.3.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region
8.4.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Enterobacteriaceae Infection Drug Market Size (2016-2027)
9.2 Latin America Enterobacteriaceae Infection Drug Market Size by Type
9.2.1 Latin America Enterobacteriaceae Infection Drug Market Size by Type (2016-2021)
9.2.2 Latin America Enterobacteriaceae Infection Drug Market Size by Type (2022-2027)
9.2.3 Latin America Enterobacteriaceae Infection Drug Market Size by Type (2016-2027)
9.3 Latin America Enterobacteriaceae Infection Drug Market Size by Application
9.3.1 Latin America Enterobacteriaceae Infection Drug Market Size by Application (2016-2021)
9.3.2 Latin America Enterobacteriaceae Infection Drug Market Size by Application (2022-2027)
9.3.3 Latin America Enterobacteriaceae Infection Drug Market Size by Application (2016-2027)
9.4 Latin America Enterobacteriaceae Infection Drug Market Size by Country
9.4.1 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2016-2021)
9.4.2 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size (2016-2027)
10.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type
10.2.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application
10.3.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country
10.4.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genentech
11.1.1 Genentech Company Details
11.1.2 Genentech Business Overview
11.1.3 Genentech Enterobacteriaceae Infection Drug Introduction
11.1.4 Genentech Revenue in Enterobacteriaceae Infection Drug Business (2016-2021)
11.1.5 Genentech Recent Development
11.2 Nanotherapeutics
11.2.1 Nanotherapeutics Company Details
11.2.2 Nanotherapeutics Business Overview
11.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Introduction
11.2.4 Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2016-2021)
11.2.5 Nanotherapeutics Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Enterobacteriaceae Infection Drug Introduction
11.3.4 Novartis Revenue in Enterobacteriaceae Infection Drug Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Enterobacteriaceae Infection Drug Introduction
11.4.4 Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Nymox Pharmaceutical
11.5.1 Nymox Pharmaceutical Company Details
11.5.2 Nymox Pharmaceutical Business Overview
11.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Introduction
11.5.4 Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2016-2021)
11.5.5 Nymox Pharmaceutical Recent Development
11.6 Sequoia Sciences
11.6.1 Sequoia Sciences Company Details
11.6.2 Sequoia Sciences Business Overview
11.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Introduction
11.6.4 Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2016-2021)
11.6.5 Sequoia Sciences Recent Development
11.7 Phico Therapeutics
11.7.1 Phico Therapeutics Company Details
11.7.2 Phico Therapeutics Business Overview
11.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Introduction
11.7.4 Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2016-2021)
11.7.5 Phico Therapeutics Recent Development
11.8 Cantab Biopharmaceuticals
11.8.1 Cantab Biopharmaceuticals Company Details
11.8.2 Cantab Biopharmaceuticals Business Overview
11.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Introduction
11.8.4 Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2016-2021)
11.8.5 Cantab Biopharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Beta-lactams Drugs
Table 3. Key Players of Carbapenems Drugs
Table 4. Key Players of Fluoroquinolones Drugs
Table 5. Key Players of Others
Table 6. Global Enterobacteriaceae Infection Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Enterobacteriaceae Infection Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Enterobacteriaceae Infection Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Enterobacteriaceae Infection Drug Market Share by Regions (2016-2021)
Table 10. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Enterobacteriaceae Infection Drug Market Share by Regions (2022-2027)
Table 12. Enterobacteriaceae Infection Drug Market Trends
Table 13. Enterobacteriaceae Infection Drug Market Drivers
Table 14. Enterobacteriaceae Infection Drug Market Challenges
Table 15. Enterobacteriaceae Infection Drug Market Restraints
Table 16. Global Enterobacteriaceae Infection Drug Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Enterobacteriaceae Infection Drug Market Share by Players (2016-2021)
Table 18. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enterobacteriaceae Infection Drug as of 2020)
Table 19. Ranking of Global Top Enterobacteriaceae Infection Drug Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Enterobacteriaceae Infection Drug Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Enterobacteriaceae Infection Drug Product Solution and Service
Table 23. Date of Enter into Enterobacteriaceae Infection Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2016-2021)
Table 27. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Enterobacteriaceae Infection Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2016-2021)
Table 31. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) & (US$ Million)
Table 63. Genentech Company Details
Table 64. Genentech Business Overview
Table 65. Genentech Enterobacteriaceae Infection Drug Product
Table 66. Genentech Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million)
Table 67. Genentech Recent Development
Table 68. Nanotherapeutics Company Details
Table 69. Nanotherapeutics Business Overview
Table 70. Nanotherapeutics Enterobacteriaceae Infection Drug Product
Table 71. Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million)
Table 72. Nanotherapeutics Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Enterobacteriaceae Infection Drug Product
Table 76. Novartis Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Enterobacteriaceae Infection Drug Product
Table 81. Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Nymox Pharmaceutical Company Details
Table 84. Nymox Pharmaceutical Business Overview
Table 85. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product
Table 86. Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million)
Table 87. Nymox Pharmaceutical Recent Development
Table 88. Sequoia Sciences Company Details
Table 89. Sequoia Sciences Business Overview
Table 90. Sequoia Sciences Enterobacteriaceae Infection Drug Product
Table 91. Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million)
Table 92. Sequoia Sciences Recent Development
Table 93. Phico Therapeutics Company Details
Table 94. Phico Therapeutics Business Overview
Table 95. Phico Therapeutics Enterobacteriaceae Infection Drug Product
Table 96. Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million)
Table 97. Phico Therapeutics Recent Development
Table 98. Cantab Biopharmaceuticals Company Details
Table 99. Cantab Biopharmaceuticals Business Overview
Table 100. Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million)
Table 101. Cantab Biopharmaceuticals Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enterobacteriaceae Infection Drug Market Share by Type: 2020 VS 2027
Figure 2. Beta-lactams Drugs Features
Figure 3. Carbapenems Drugs Features
Figure 4. Fluoroquinolones Drugs Features
Figure 5. Others Features
Figure 6. Global Enterobacteriaceae Infection Drug Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Enterobacteriaceae Infection Drug Report Years Considered
Figure 11. Global Enterobacteriaceae Infection Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Enterobacteriaceae Infection Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Enterobacteriaceae Infection Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Enterobacteriaceae Infection Drug Market Share by Regions (2022-2027)
Figure 15. Global Enterobacteriaceae Infection Drug Market Share by Players in 2020
Figure 16. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enterobacteriaceae Infection Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Enterobacteriaceae Infection Drug Revenue in 2020
Figure 18. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Enterobacteriaceae Infection Drug Market Share by Type (2016-2027)
Figure 22. North America Enterobacteriaceae Infection Drug Market Share by Application (2016-2027)
Figure 23. North America Enterobacteriaceae Infection Drug Market Share by Country (2016-2027)
Figure 24. United States Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Enterobacteriaceae Infection Drug Market Share by Type (2016-2027)
Figure 28. Europe Enterobacteriaceae Infection Drug Market Share by Application (2016-2027)
Figure 29. Europe Enterobacteriaceae Infection Drug Market Share by Country (2016-2027)
Figure 30. Germany Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Region (2016-2027)
Figure 40. China Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Enterobacteriaceae Infection Drug Market Share by Type (2016-2027)
Figure 48. Latin America Enterobacteriaceae Infection Drug Market Share by Application (2016-2027)
Figure 49. Latin America Enterobacteriaceae Infection Drug Market Share by Country (2016-2027)
Figure 50. Mexico Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Country (2016-2027)
Figure 56. Turkey Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genentech Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021)
Figure 60. Nanotherapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021)
Figure 63. Nymox Pharmaceutical Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021)
Figure 64. Sequoia Sciences Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021)
Figure 65. Phico Therapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021)
Figure 66. Cantab Biopharmaceuticals Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---